Clinical Features, Response to Treatment, and Outcomes of IgG4-Related Sclerosing Cholangitis Atsushi Tanaka, Susumu Tazuma, Kazuichi Okazaki, Takahiro.

Slides:

Advertisements

Similar presentations

Risk of Neoplasia After Colectomy in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis Lauranne A.A.P. Derikx, Loes H.C.

Advertisements

Patients With NASH and Cryptogenic Cirrhosis Are Less Likely Than Those With Hepatitis C to Receive Liver Transplants Jacqueline G. O'Leary, Carmen Landaverde,

The Role of Psychosocial Care in Adapting to Health Care Reform

Abnormal Liver Tests and Fatty Liver on Ultrasound

Thrombocytopenia With Abnormal Liver Function Tests

Survival of Patients With Superficial Esophageal Adenocarcinoma After Endoscopic Treatment vs Surgery Saowanee Ngamruengphong, Herbert C. Wolfsen, Michael.

Celiac Disease and Persistent Symptoms

Katsunori Matsueda, Tatsuya Toyokawa

A Shocking Cystory Clinical Gastroenterology and Hepatology

Prevalence of Irritable Bowel Syndrome–type Symptoms in Patients With Celiac Disease: A Meta-analysis Anita Sainsbury, David S. Sanders, Alexander C.

Liver Cirrhosis Is Associated With Venous Thromboembolism Among Hospitalized Patients in a Nationwide US Study Harry Wu, Geoffrey C. Nguyen Clinical.

Stephen A. Harrison, MD, FACP Clinical Gastroenterology and Hepatology

Many Patients With Primary Sclerosing Cholangitis and Increased Serum Levels of Carbohydrate Antigen 19-9 Do Not Have Cholangiocarcinoma Emmanouil Sinakos,

Metoclopramide Nasal Spray Reduces Symptoms of Gastroparesis in Women, but not Men, With Diabetes: Results of a Phase 2B Randomized Study Henry P. Parkman,

Abstracts from Around the World

Clinical Features, Treatment, and Survival of Patients With Colorectal Cancer With or Without Inflammatory Bowel Disease Raja Affendi Raja Ali, Cara.

Pancreatic Duct Drainage for the Treatment of a Huge Pancreatic Cyst Associated With Autoimmune Pancreatitis Hiroyuki Matsubayashi, Toru Matsui, Hiroyuki.

Activity-Based Costing and Management in a Hospital-Based GI Unit

Alan J. Wigg, Rosemary McCormick, Rachel Wundke, Richard J. Woodman

Rawad Mounzer, Shahid M. Malik, John Nasr, Bahar Madani, Michael E

Cholangioscopy by Using Narrow-Band Imaging and Transpapillary Radiotherapy for Mucin-Producing Bile Duct Tumor Xin–Liang Lu, Takao Itoi, Kensuke Kubota

Amie L. Harvey, Tommy Yen, Anand Kunda

AGA Clinical Practice Update on Functional Gastrointestinal Symptoms in Patients With Inflammatory Bowel Disease: Expert Review Jean-Frederic Colombel,

Rapid Disappearance of a Pancreatic Cyst After Steroid Therapy in a Patient With Autoimmune Pancreatitis Terumi Kamisawa, Hajime Anjiki, Naoto Egawa

Metastatic Malignant Melanoma of the Gastrointestinal Tract

Abnormal Liver Tests and Fatty Liver on Ultrasound

Thurarshen Jeyalingam, Yuto Shimamura, Christopher Teshima

Inflammatory Bowel Disease Is Associated With Poor Outcomes of Patients With Primary Sclerosing Cholangitis Jing Hieng Ngu, Richard Blair Gearry, Andrew.

William D. Leslie Clinical Gastroenterology and Hepatology

Impact of Liver Disease, Alcohol Abuse, and Unintentional Ingestions on the Outcomes of Acetaminophen Overdose Robert P. Myers, Abdel Aziz M. Shaheen,

Ramesh Kumar, Masiullah, Pintu Kumar Singh

Endoscopic Ultrasound–Guided Cholecystoduodenostomy for Acute Cholecystitis in a Patient With Thrombocytopenia and End-Stage Liver Disease Awaiting Transplantation

Issue Highlights Clinical Gastroenterology and Hepatology

Effects of Serum Aspartate Aminotransferase Levels in Patients With Autoimmune Hepatitis Influence Disease Course and Outcome Thawab Al–Chalabi, James.

David H. Bruining, William J. Sandborn

Eric S. Orman, Marwan Ghabril, Naga Chalasani

Peter Bytzer Clinical Gastroenterology and Hepatology

Cholelithiasis in a Patient With History of Cholecystectomy

Rebecca M. Lovell, Alexander C. Ford

Patient-Reported Outcomes of Cirrhosis

Primary Sclerosing Cholangitis and Disease Distribution in Inflammatory Bowel Disease Aoibhlinn O'Toole, Alaa Alakkari, Denise Keegan, Glen Doherty, Hugh.

Colorectal Cancer Screening: How to Stop a Moving Target

Issue Highlights Clinical Gastroenterology and Hepatology

Effects of Different Coping Strategies on Physical and Mental Health of Patients With Irritable Bowel Syndrome Lilian Dindo, PhD Clinical Gastroenterology.

Association Between Reduced Levels of Alkaline Phosphatase and Survival Times of Patients With Primary Sclerosing Cholangitis Lina Lindström, Rolf Hultcrantz,

Volume 151, Issue 4, Pages (October 2016)

All Wired Up: Migration of Endovascular Coils to the Common Bile Duct

Nicolas Williet, William J. Sandborn, Laurent Peyrin–Biroulet

Hepatic Cyst? Clinical Gastroenterology and Hepatology

Thrombocytopenia With Abnormal Liver Function Tests

Patrícia Andrade, Susana Lopes, Guilherme Macedo

Hepatitis C Virus Infection, Age, and Hispanic Ethnicity Increase Mortality From Liver Cancer in the United States Zobair M. Younossi, Maria Stepanova

A 27-Year-Old Woman With Constipation: Diagnosis and Treatment

A 42–Year–Old Woman With a New Diagnosis of Sclerosing Cholangitis

Coagulation in Liver Disease: A Guide for the Clinician

Issue Highlights Clinical Gastroenterology and Hepatology

Risk of Pancreatitis in Patients With Celiac Disease: Is Autoimmune Pancreatitis a Biologically Plausible Mechanism? John S. Leeds, David S. Sanders

Laura E. Targownik, Alice Nabalamba

Issue Highlights Clinical Gastroenterology and Hepatology

Coloduodenal Fistula in Crohn’s Disease

Patients With NASH and Cryptogenic Cirrhosis Are Less Likely Than Those With Hepatitis C to Receive Liver Transplants Jacqueline G. O'Leary, Carmen Landaverde,

Rintaro Hashimoto, Akimichi Chonan

Adverse Outcomes: Why Bad Things Happen to Good People

Medical Therapy for Refractory Pediatric Crohn’s Disease

Rintaro Hashimoto, Akimichi Chonan

The Role of Psychosocial Care in Adapting to Health Care Reform

Subcapsular Hepatic Fluid Collection Caused by Cardiac Dysfunction

Metastatic Malignant Melanoma of the Gastrointestinal Tract

Statin Use Is Associated With Improved Outcomes of Patients With Primary Sclerosing Cholangitis Knut Stokkeland, Jonas Höijer, Matteo Bottai, Karin Söderberg-Löfdal,

Jordan E. Axelrad, Sharyle A. Fowler, Sonia Friedman, Ashwin N

Presentation transcript:

Clinical Features, Response to Treatment, and Outcomes of IgG4-Related Sclerosing Cholangitis Atsushi Tanaka, Susumu Tazuma, Kazuichi Okazaki, Takahiro Nakazawa, Kazuo Inui, Tsutomu Chiba, Hajime Takikawa Clinical Gastroenterology and Hepatology Volume 15, Issue 6, Pages 920-926.e3 (June 2017) DOI: 10.1016/j.cgh.2016.12.038 Copyright © 2017 AGA Institute Terms and Conditions

Figure 1 Distribution of age at presentation, for patients with IgG4-related sclerosing cholangitis. Clinical Gastroenterology and Hepatology 2017 15, 920-926.e3DOI: (10.1016/j.cgh.2016.12.038) Copyright © 2017 AGA Institute Terms and Conditions

Figure 2 Symptoms at presentation, for patients with IgG4-related sclerosing cholangitis. Clinical Gastroenterology and Hepatology 2017 15, 920-926.e3DOI: (10.1016/j.cgh.2016.12.038) Copyright © 2017 AGA Institute Terms and Conditions

Figure 3 Distribution of cholangiographic findings in patients with IgG4-related sclerosing cholangitis, according to the classification proposed by Nakazawa et al.23 Clinical Gastroenterology and Hepatology 2017 15, 920-926.e3DOI: (10.1016/j.cgh.2016.12.038) Copyright © 2017 AGA Institute Terms and Conditions

Figure 4 The cumulative overall survival rate for patients with IgG4-related sclerosing cholangitis. Clinical Gastroenterology and Hepatology 2017 15, 920-926.e3DOI: (10.1016/j.cgh.2016.12.038) Copyright © 2017 AGA Institute Terms and Conditions

Figure 5 The cumulative survival free from death caused by liver-related or bile duct–related diseases for patients with IgG4-related sclerosing cholangitis. Clinical Gastroenterology and Hepatology 2017 15, 920-926.e3DOI: (10.1016/j.cgh.2016.12.038) Copyright © 2017 AGA Institute Terms and Conditions

Supplementary Figure 1 Serum alkaline phosphatase levels at presentation in patients with IgG4-related sclerosing cholangitis. Clinical Gastroenterology and Hepatology 2017 15, 920-926.e3DOI: (10.1016/j.cgh.2016.12.038) Copyright © 2017 AGA Institute Terms and Conditions

Supplementary Figure 2 Serum IgG4 levels at presentation in patients with IgG4-related sclerosing cholangitis. Clinical Gastroenterology and Hepatology 2017 15, 920-926.e3DOI: (10.1016/j.cgh.2016.12.038) Copyright © 2017 AGA Institute Terms and Conditions

Supplementary Figure 3 The cumulative rate of restenosis in patients with IgG4-related sclerosing cholangitis. Clinical Gastroenterology and Hepatology 2017 15, 920-926.e3DOI: (10.1016/j.cgh.2016.12.038) Copyright © 2017 AGA Institute Terms and Conditions

Supplementary Figure 4 The cumulative survival free from death due to liver or bile duct-related diseases, stratified according to the presence of restenosis. Clinical Gastroenterology and Hepatology 2017 15, 920-926.e3DOI: (10.1016/j.cgh.2016.12.038) Copyright © 2017 AGA Institute Terms and Conditions